体外診断市場（タイプ別、技術別、用途別、およびエンドユーザー別）- 世界の機会分析と業界予測（2025〜2030年）

レポートナンバー　0000040865

体外診断市場（タイプ別、技術別、用途別、およびエンドユーザー別）- 世界の機会分析と業界予測（2025〜2030年）

Next Move Strategy Consulting

In-Vitro Diagnostic Market by Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Others), and by End User (Stand Alone, Laboratory, Hospitals, Academics and Medical Schools, Point of Care Testing, and Other End Users) - Global Opportunity Analysis and Industry Forecast, 2025-2030

発刊日 2024/12

言語英語

体裁PDF/490ページ

ライセンス/価格490ページ

0000040865

Single	3,975USD
Multi	4,975USD
Enterprise	6,975USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

世界の体外診断（IVD）市場規模は、2024年に893億2,000万米ドルと評価され、2025年から2030年までのCAGRは3.9%で、2030年までに1,140億2,000万米ドルに達すと予測されています。

がん、心血管疾患、糖尿病、さまざまな感染症などの慢性疾患や感染症の有病率の上昇により、体外診断（IVD）市場における診断検査の需要が大幅に増加しています。医療システムがこうした増大する健康課題に対処しようとする中、早期発見、疾患のモニタリング、個別化された治療戦略への注目が高まっています。世界保健機関によると、非感染性疾患（NCD）は年間4,100万人という驚異的な死亡の原因となっており、全世界の死亡者数の約74%を占めています。NCDの中で、死亡率統計で最も多いのは心血管疾患で、毎年1,790万人が死亡しており、次いでがんが930万人、慢性呼吸器疾患が410万人、糖尿病が200万人となっています。迅速かつ正確な診断情報を提供できる体外診断は、積極的な医療介入を促進し、患者の転帰を改善するために不可欠です。世界中の医療システムが慢性疾患や感染症の負担の増大に対抗する取り組みを強化するにつれ、IVD市場は大幅に拡大する態勢が整っています。

しかし、研究、開発、規制当局の承認に関連する高額なコストが、体外診断（IVD）市場の成長を抑制する大きな要因となっています。この分野で事業を展開する企業は、研究開発の複雑な状況を乗り切るために多額の財務投資を行う必要があります。この投資には、精度と信頼性を確保するための大規模な臨床試験、臨床検査、製品の改良が含まれます。さらに、FDAなどの当局から規制当局の承認を得るには、厳格な基準を厳守する必要があり、経済的負担が増大します。こうした財務上の制約は、潜在的な市場参入者の意欲をそぎ、拡大の取り組みを制限し、それによって業界全体の成長を妨げる可能性があります。

それどころか、ポイントオブケア検査（POCT）は、今後数年間の体外診断（IVD）市場にとって大きなチャンスとなります。POCTは、救急外来、救急車、遠隔医療現場など、即時の結果が重要な状況で特に価値があります。これらのテクノロジーは、感染症、心臓マーカー、血糖値、妊娠などを含むさまざまな状態の迅速な検査を提供します。これにより、医療提供者は患者の状態を迅速に評価し、タイムリーな治療決定を行うことができます。POCTを従来のIVD方法と統合することで、医療提供者は診断能力を強化し、より効率的で患者中心のケアを実現できます。この統合によりワークフローが合理化され、より迅速な診断と治療の開始が可能になり、最終的には患者の転帰が改善されます。

セグメントの概要

体外診断市場は、ソリューション、用途、組織規模、地域に基づいて分割されています。

タイプ別に、市場は試薬、機器、ソフトウェアとサービスに分類されます。
技術別に、市場は免疫診断、血液学、分子診断、組織診断、臨床化学、およびその他のIVD技術に分類されます。
用途別に、市場は感染症、がん、心疾患、免疫系疾患、腎臓疾患、胃腸疾患、その他の用途に分類されます。
エンドユーザー別に、市場は独立した研究室、病院、大学および医学部、ポイントオブケア検査、およびその他のエンドユーザーに分類されます。
地域別に、市場は北アメリカ、ヨーロッパ、アジア太平洋地域、世界のその他の地域（RoW）に分類されます。

地域分析

北アメリカ地域が体外診断市場を独占

北アメリカ地域は、糖尿病、心血管疾患、がんなどの慢性疾患の有病率の上昇により、世界の体外診断薬（IVD）市場シェアの約40％を占めています。全米慢性疾患ディレクター協会（National Association of Chronic Disease Directors）によると、アメリカにおける死亡者の3人に1人は心血管疾患によるもので、年間合計859,000人が死亡しています。この多大な負担により、慢性疾患の診断、監視、管理に不可欠なIVDの需要が増加しています。

革新的なテクノロジーと診断技術の進歩により、医療提供者はリスクのある個人をより適切に特定し、個人のニーズに合わせて治療計画を調整し、患者の転帰を改善することができます。 Bio-Rad Laboratories Inc.、Becton, Dickinson and Company、Abbott Laboratories、Quest Diagnosticsなどの著名な企業の存在により、イノベーション、研究開発活動、コラボレーションを通じて市場の成長がさらに促進されます。

たとえば、2023年1月、Bio-Rad Laboratories Inc.は、米国食品医薬品局（FDA）によって承認され、体外診断医療機器に関するヨーロッパ連合の規制に準拠した製品であるCFX Opus 96 DxリアルタイムPCRシステムを導入しました。このシステムは、ユーザーフレンドリーなインターフェイスと直感的なソフトウェアを備えており、操作が簡素化され、ラボスタッフのトレーニング要件が最小限に抑えられるため、市場の成長が促進されます。

主要な市場プレーヤー

Roche Holding AG
Abbott Laboratories
Thermo Fisher Scientific Inc
Danaher Corporation
Becton, Dickinson and Company
Siemens Healthineers AG
bioMérieux SA
Sysmex Corporation
QIAGEN N.V.
Bio-Rad Laboratories, Inc.
DiaSorin
Adaltis S.r.l
DIESSE Diagnostica Senese
Sentinel Diagnostics
Sclavo Diagnostics International

レポート詳細

3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1. RISING INCIDENCES OF CHRONIC AND INFECTIOUS DISEASES TO FUEL MARKET GROWTH
3.2.1.2. RAPID ADVANCEMENTS IN MEDICAL TECHNOLOGY AND RESEARCH STRENGTHENS THE MARKET
3.2.1.3. AWARENESS OF EARLY DETECTION AND PREVENTION OF DISEASES AMONG INDIVIDUALS
3.2.2 RESTRAINTS
3.2.2.1. HIGH COST OF IVD RESTRANS INDUSTRY GROWTH
3.2.2.1 STRINGENT REGULATORY POLICIES TO IMPEDE THE GROWTH OF THE MARKET
3.2.3 OPPORTUNITIES
3.2.3.1. INTRODUCTION OF NEW TECHNOLOGY IN IVD TO INTRODUCE FUTURE OPPORTUNITIES
3.2.3.1 EVOLUTION IN THE TECHNOLOGIES ALLOWS FUTURE MARKET PROSPECTS

4. GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.2. REAGENTS
4.2.1 REAGENTS MARKET, BY REGION
4.3. INSTRUMENTS
4.3.1 INSTRUMENTS MARKET, BY REGION
4.4. SOFTWARE AND SERVICES
4.4.1 SOFTWARE AND SERVICES MARKET, BY REGION

5. GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
5.1. OVERVIEW
5.2. IMMUNODIAGNOSTICS
5.2.1 GLOBAL IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
5.2.1.1. ELISA MARKET, BY REGION
5.2.1.2. RAPID TESTS MARKET, BY REGION
5.2.1.3. ELISPOT MARKET, BY REGION
5.2.1.4. RADIOIMMUNOASSAY (RIA) MARKET, BY REGION
5.2.1.5. WESTERN BLOT MARKET, BY REGION
5.2.2 IMMUNODIAGNOSTICS MARKET, BY REGION
5.3. HEMATOLOGY
5.3.1 HEMATOLOGY MARKET, BY REGION
5.4. MOLECULAR DIAGNOSTICS
5.4.1 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
5.4.1.1. PCR MARKET, BY REGION
5.4.1.2. INAAT MARKET, BY REGION
5.4.1.3. HYBRIDIZATION MARKET, BY REGION
5.4.1.4. DNA DIAGNOSTICS MARKET, BY REGION
5.4.1.5. MICROARRAY MARKET, BY REGION
5.4.1.6. OTHERS MARKET, BY REGION
5.4.2 MOLECULAR DIAGNOSTICS MARKET, BY REGION
5.5. TISSUE DISGNOSTICS
5.5.1 TISSUE DISGNOSTICS MARKET, BY REGION
5.6. CLINICAL CHEMISTRY
5.6.1 GLOBAL CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
5.6.1.1. BASIC METABOLIC PANEL MARKET, BY REGION
5.6.1.2. LIVER PANEL MARKET, BY REGION
5.6.1.3. RENAL PROFILE MARKET, BY REGION
5.6.1.4. LIPID PROFILE MARKET, BY REGION
5.6.1.5. THYROID FUNCTION PANEL MARKET, BY REGION
5.6.1.6. ELECTROLYTE PANEL MARKET, BY REGION
5.6.1.7. SPECIALITY CHEMICALS MARKET, BY REGION
5.6.2 CLINICAL CHEMISTRY MARKET, BY REGION
5.7. OTHER IVD TECHNIQUES
5.7.1 OTHER IVD TECHNIQUES MARKET, BY REGION

6. GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
6.1. OVERVIEW
6.2. INFECTIOUS DISEASES
6.2.1 INFECTIOUS DISEASES MARKET, BY REGION
6.3. CANCER
6.3.1 CANCER MARKET, BY REGION
6.4. CARDIAC DISEASES
6.4.1 CARDIAC DISEASES MARKET, BY REGION
6.5. IMMUNE SYSTEM DISORDERS
6.5.1 IMMUNE SYSTEM DISORDERS MARKET, BY REGION
6.6. NEPHROLOGICAL DISEASES
6.6.1 NEPHROLOGICAL DISEASES MARKET, BY REGION
6.7. GASTROINTESTINAL DISEASES
6.7.1 GASTROINTESTINAL DISEASES MARKET, BY REGION
6.8. OTHER INDICATIONS
6.8.1 OTHER INDICATIONS MARKET, BY REGION

7. GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
7.1. OVERVIEW
7.2. STAND ALONE LABORATORY
7.2.1 STAND ALONE LABORATORY MARKET, BY REGION
7.3. HOSPITALS
7.3.1 HOSPITALS MARKET, BY REGION
7.4. ACADEMICS AND MEDICAL SCHOOLS
7.4.1 ACADEMICS AND MEDICAL SCHOOLS MARKET, BY REGION
7.5. POINT OF CARE TESTING
7.5.1 POINT OF CARE TESTING MARKET, BY REGION
7.6. OTHERS
7.6.1 OTHERS MARKET, BY REGION

8. GLOBAL IN VITRO DIAGNOSTICS (IVD) MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.2.2 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.2.2.1. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.2.2.2. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.2.2.3. NORTH AMERICA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.2.3 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.2.4 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.2.5 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY COUNTRY
8.2.5.1. U.S.
8.2.5.1.1. U.S. IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.2.5.1.2. U.S. IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.2.5.1.2.1. U.S. IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.2.5.1.2.2. U.S. MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.2.5.1.2.3. U.S. CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.2.5.1.3. U.S. IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.2.5.1.4. U.S. IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.2.5.2. CANADA
8.2.5.2.1. CANADA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.2.5.2.2. CANADA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.2.5.2.2.1. CANADA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.2.5.2.2.2. CANADA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.2.5.2.2.3. CANADA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.2.5.2.3. CANADA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.2.5.2.4. CANADA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.2.5.3. MEXICO
8.2.5.3.1. MEXICO IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.2.5.3.2. MEXICO IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.2.5.3.2.1. MEXICO IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.2.5.3.2.2. MEXICO MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.2.5.3.2.3. MEXICO CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.2.5.3.3. MEXICO IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.2.5.3.4. MEXICO IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.3. EUROPE
8.3.1 EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.3.2 EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.3.2.1. EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.3.2.2. EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.3.2.3. EUROPE CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.3.3 EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.3.4 EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.3.5 EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY COUNTRY
8.3.5.1. GERMANY
8.3.5.1.1. GERMANY IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.3.5.1.2. GERMANY IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.3.5.1.2.1. GERMANY IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.1.2.2. GERMANY MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.1.2.3. GERMANY CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.3.5.1.3. GERMANY IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.3.5.1.4. GERMANY IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.3.5.2. FRANCE
8.3.5.2.1. FRANCE IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.3.5.2.2. FRANCE IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.3.5.2.2.1. FRANCE IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.2.2.2. FRANCE MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.2.2.3. FRANCE CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.3.5.2.3. FRANCE IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.3.5.2.4. FRANCE IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.3.5.3. UK
8.3.5.3.1. UK IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.3.5.3.2. UK IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.3.5.3.2.1. UK IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.3.2.2. UK MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.3.2.3. UK CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.3.5.3.3. UK IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.3.5.3.4. UK IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.3.5.4. ITALY
8.3.5.4.1. ITALY IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.3.5.4.2. ITALY IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.3.5.4.2.1. ITALY IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.4.2.2. ITALY MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.4.2.3. ITALY CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.3.5.4.3. ITALY IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.3.5.4.4. ITALY IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.3.5.5. SPAIN
8.3.5.5.1. SPAIN IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.3.5.5.2. SPAIN IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.3.5.5.2.1. SPAIN IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.5.2.2. SPAIN MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.5.2.3. SPAIN CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.3.5.5.3. SPAIN IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.3.5.5.4. SPAIN IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.3.5.6. REST OF EUROPE
8.3.5.6.1. REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.3.5.6.2. REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.3.5.6.2.1. REST OF EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.6.2.2. REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.3.5.6.2.3. REST OF EUROPE CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.3.5.6.3. REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.3.5.6.4. REST OF EUROPE IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.4. ASIA-PACIFIC
8.4.1 ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.4.2 ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.4.2.1. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.4.2.2. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.4.2.3. ASIA-PACIFIC CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.4.3 ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.4.4 ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.4.5 ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY COUNTRY
8.4.5.1. INDIA
8.4.5.1.1. INDIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.4.5.1.2. INDIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.4.5.1.2.1. INDIA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.1.2.2. INDIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.1.2.3. INDIA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.4.5.1.3. INDIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.4.5.1.4. INDIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.4.5.2. CHINA
8.4.5.2.1. CHINA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.4.5.2.2. CHINA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.4.5.2.2.1. CHINA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.2.2.2. CHINA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.2.2.3. CHINA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.4.5.2.3. CHINA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.4.5.2.4. CHINA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.4.5.3. JAPAN
8.4.5.3.1. JAPAN IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.4.5.3.2. JAPAN IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.4.5.3.2.1. JAPAN IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.3.2.2. JAPAN MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.3.2.3. JAPAN CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.4.5.3.3. JAPAN IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.4.5.3.4. JAPAN IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.4.5.4. AUSTRALIA
8.4.5.4.1. AUSTRALIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.4.5.4.2. AUSTRALIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.4.5.4.2.1. AUSTRALIA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.4.2.2. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.4.2.3. AUSTRALIA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.4.5.4.3. AUSTRALIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.4.5.4.4. AUSTRALIA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.4.5.5. SOUTH KOREA
8.4.5.5.1. SOUTH KOREA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.4.5.5.2. SOUTH KOREA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.4.5.5.2.1. SOUTH KOREA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.5.2.2. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.5.2.3. SOUTH KOREA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.4.5.5.3. SOUTH KOREA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.4.5.5.4. SOUTH KOREA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.4.5.6. REST OF ASIA-PACIFIC
8.4.5.6.1. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.4.5.6.2. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.4.5.6.2.1. REST OF ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.6.2.2. REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.4.5.6.2.3. REST OF ASIA-PACIFIC CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.4.5.6.3. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.4.5.6.4. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.5. REST OF WORLD
8.5.1 REST OF WORLD IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.5.2 REST OF WORLD IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.5.2.1. REST OF WORLD IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.5.2.2. REST OF WORLD MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.5.2.3. REST OF WORLD CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.5.3 REST OF WORLD IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.5.4 REST OF WORLD IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.5.5 REST OF WORLD IN VITRO DIAGNOSTICS (IVD) MARKET, BY COUNTRY
8.5.5.1. LATIN AMERICA
8.5.5.1.1. LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.5.5.1.2. LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.5.5.1.2.1. LATIN AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.5.5.1.2.2. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.5.5.1.2.3. LATIN AMERICA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.5.5.1.3. LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.5.5.1.4. LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.5.5.2. MIDDLE EAST
8.5.5.2.1. MIDDLE EAST IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.5.5.2.2. MIDDLE EAST IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.5.5.2.2.1. MIDDLE EAST IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.5.5.2.2.2. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.5.5.2.2.3. MIDDLE EAST CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.5.5.2.3. MIDDLE EAST IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.5.5.2.4. MIDDLE EAST IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER
8.5.5.3. AFRICA
8.5.5.3.1. AFRICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY PRODUCT TYPE
8.5.5.3.2. AFRICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY TECHNIQUE
8.5.5.3.2.1. AFRICA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE
8.5.5.3.2.2. AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE
8.5.5.3.2.3. AFRICA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE
8.5.5.3.3. AFRICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY APPLICATION
8.5.5.3.4. AFRICA IN VITRO DIAGNOSTICS (IVD) MARKET, BY ENDUSER

9. COMPANY PROFILES
9.1. BIOMERIEUX
9.1.1 COMPANY OVERVIEW
9.1.2 COMPANY SNAPSHOT
9.1.3 OPERATING BUSINESS SEGMENTS
9.1.5 BUSINESS PERFORMANCE
9.1.6 SALES BY BUSINESS SEGMENT
9.1.7 SALES BY GEOGRAPHIC SEGMENT
9.1.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.1.9 PRIMARY MARKET COMPETITORS
9.2. ROCHE HOLDING
9.2.1 COMPANY OVERVIEW
9.2.2 COMPANY SNAPSHOT
9.2.3 OPERATING BUSINESS SEGMENTS
9.2.5 BUSINESS PERFORMANCE
9.2.6 SALES BY BUSINESS SEGMENT
9.2.7 SALES BY GEOGRAPHIC SEGMENT
9.2.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.2.9 PRIMARY MARKET COMPETITORS
9.3. BIO-RAD LABORATORIES, INC.
9.3.1 COMPANY OVERVIEW
9.3.2 COMPANY SNAPSHOT
9.3.3 OPERATING BUSINESS SEGMENTS
9.3.4 PRODUCT PORTFOLIO
9.3.5 BUSINESS PERFORMANCE
9.3.6 SALES BY GEOGRAPHIC SEGMENT
9.3.7 BIO-RAD LABORATORIES, INC: BUSINESS SEGMENT
9.3.8 SALES BY GEOGRAPHIC SEGMENT
9.3.9 BIO-RAD LABORATORIES, INC: GEOGRAPHIC SEGMENT
9.3.10 KEY STRATEGIC MOVES & DEVELOPMENTS
9.3.11 PRIMARY MARKET COMPETITORS
9.4. BECTON, DICKINSON AND COMPANY
9.4.1 COMPANY OVERVIEW
9.4.2 COMPANY SNAPSHOT
9.4.3 OPERATING BUSINESS SEGMENTS
9.4.4 PRODUCT PORTFOLIO
9.4.5 BUSINESS PERFORMANCE
9.4.6 SALES BY BUSINESS SEGMENT
9.4.7 BECTON, DICKINSON AND COMPANY: BUSINESS SEGMENT
9.4.8 SALES BY GEOGRAPHIC SEGMENT
9.4.9 BECTON, DICKINSON AND COMPANY: GEOGRAPHIC SEGMENT
9.4.10 KEY STRATEGIC MOVES & DEVELOPMENTS
9.4.11 PRIMARY MARKET COMPETITORS
9.5. SIEMENS HEALTHINEERS AG
9.5.1 COMPANY OVERVIEW
9.5.2 COMPANY SNAPSHOT
9.5.3 OPERATING BUSINESS SEGMENTS
9.5.4 PRODUCT PORTFOLIO
9.5.5 BUSINESS PERFORMANCE
9.5.6 SALES BY BUSINESS SEGMENT
9.5.7 SALES BY GEOGRAPHIC SEGMENT
9.5.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.5.9 PRIMARY MARKET COMPETITORS
9.6. SYSMEX CORPORATION
9.6.1 COMPANY OVERVIEW
9.6.2 COMPANY SNAPSHOT
9.6.3 OPERATING BUSINESS SEGMENTS
9.6.4 PRODUCT PORTFOLIO
9.6.5 BUSINESS PERFORMANCE
9.6.6 SALES BY BUSINESS SEGMENT
9.6.7 SALES BY GEOGRAPHIC SEGMENT
9.6.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.6.9 PRIMARY MARKET COMPETITORS
9.7. THERMO FISHER SCIENTIFIC INC.
9.7.1 COMPANY OVERVIEW
9.7.2 COMPANY SNAPSHOT
9.7.3 OPERATING BUSINESS SEGMENTS
9.7.4 PRODUCT PORTFOLIO
9.7.5 BUSINESS PERFORMANCE
9.7.6 SALES BY BUSINESS SEGMENT
9.7.7 SALES BY GEOGRAPHIC SEGMENT
9.7.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.7.9 PRIMARY MARKET COMPETITORS
9.8. ABBOTT LABORATORIES
9.8.1 COMPANY OVERVIEW
9.8.2 COMPANY SNAPSHOT
9.8.3 OPERATING BUSINESS SEGMENTS
9.8.4 PRODUCT PORTFOLIO
9.8.5 BUSINESS PERFORMANCE
9.8.6 SALES BY BUSINESS SEGMENT
9.8.7 SALES BY GEOGRAPHIC SEGMENT
9.8.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.8.9 PRIMARY MARKET COMPETITORS
9.9. QIAGEN N.V.
9.9.1 COMPANY OVERVIEW
9.9.2 COMPANY SNAPSHOT
9.9.3 PRODUCT PORTFOLIO
9.9.4 BUSINESS PERFORMANCE
9.9.5 SALES BY GEOGRAPHIC SEGMENT
9.9.6 KEY STRATEGIC MOVES & DEVELOPMENTS
9.9.7 PRIMARY MARKET COMPETITORS
9.10. DANAHER CORPORATION
9.10.1 COMPANY OVERVIEW
9.10.2 COMPANY SNAPSHOT
9.10.3 OPERATING BUSINESS SEGMENTS
9.10.4 PRODUCT PORTFOLIO
9.10.5 BUSINESS PERFORMANCE
9.10.6 SALES BY BUSINESS SEGMENT
9.10.7 KEY STRATEGIC MOVES & DEVELOPMENTS
9.10.8 PRIMARY MARKET COMPETITORS

2. IN VITRO DIAGNOSTICS (IVD) MARKET - EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2022 - 2030, MILLION USD

LIST OF TABLES
TABLE 1. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 2. REAGENTS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 3. INSTRUMENTS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 4. SOFTWARE AND SERVICES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 5. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 6. GLOBAL IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 7. ELISA MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 8. RAPID TESTS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 9. ELISPOT MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 10. RADIOIMMUNOASSAY (RIA) MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 11. WESTERN BLOT MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 12. IMMUNODIAGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 13. HEMATOLOGY MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 15. PCR MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 16. INAAT MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 17. HYBRIDIZATION MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 18. DNA DIAGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 19. MICROARRAY MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 20. OTHERS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 21. MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 22. TISSUE DISGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 23. GLOBAL CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 24. BASIC METABOLIC PANEL MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 25. LIVER PANEL MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 26. RENAL PROFILE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 27. LIPID PROFILE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 28. THYROID FUNCTION PANEL MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 29. ELECTROLYTE PANEL MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 30. SPECIALITY CHEMICALS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 31. CLINICAL CHEMISTRY MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 32. OTHER IVD TECHNIQUES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 33. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 34. INFECTIOUS DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 35. CANCER MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 36. CARDIAC DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 37. IMMUNE SYSTEM DISORDERS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 38. NEPHROLOGICAL DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 39. GASTROINTESTINAL DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 40. OTHER INDICATIONS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 41. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 42. STAND ALONE LABORATORY MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 43. HOSPITALS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 44. ACADEMICS AND MEDICAL SCHOOLS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 45. POINT OF CARE TESTING MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 46. OTHERS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 47. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 48. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 49. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 50. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 51. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 52. NORTH AMERICA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 53. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 54. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 55. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 56. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 57. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 58. U.S. IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 59. U.S. MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 60. U.S. CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 61. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 62. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 63. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 64. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 65. CANADA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 66. CANADA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 67. CANADA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 68. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 69. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 70. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 71. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 72. MEXICO IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 73. MEXICO MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 74. MEXICO CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 75. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 76. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 77. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 78. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 79. EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 80. EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 81. EUROPE CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 82. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 83. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 84. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 85. GERMANY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 86. GERMANY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 87. GERMANY IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 88. GERMANY MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 89. GERMANY CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 90. GERMANY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 91. GERMANY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 92. FRANCE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 93. FRANCE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 94. FRANCE IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 95. FRANCE MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 96. FRANCE CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 97. FRANCE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 98. FRANCE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 99. UK IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 100. UK IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 101. UK IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 102. UK MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 103. UK CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 104. UK IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 105. UK IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 106. ITALY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 107. ITALY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 108. ITALY IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 109. ITALY MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 110. ITALY CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 111. ITALY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 112. ITALY IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 113. SPAIN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 114. SPAIN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 115. SPAIN IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 116. SPAIN MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 117. SPAIN CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 118. SPAIN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 119. SPAIN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 120. REST OF EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 121. REST OF EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 122. REST OF EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 123. REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 124. REST OF EUROPE CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 125. REST OF EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 126. REST OF EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 127. ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 128. ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 129. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 130. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 131. ASIA-PACIFIC CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 132. ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 133. ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 134. ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 135. INDIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 136. INDIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 137. INDIA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 138. INDIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 139. INDIA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 140. INDIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 141. INDIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 142. CHINA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 143. CHINA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 144. CHINA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 145. CHINA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 146. CHINA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 147. CHINA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 148. CHINA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 149. JAPAN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 150. JAPAN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 151. JAPAN IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 152. JAPAN MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 153. JAPAN CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 154. JAPAN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 155. JAPAN IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 156. AUSTRALIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 157. AUSTRALIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 158. AUSTRALIA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 159. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 160. AUSTRALIA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 161. AUSTRALIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 162. AUSTRALIA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 163. SOUTH KOREA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 164. SOUTH KOREA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 165. SOUTH KOREA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 166. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 167. SOUTH KOREA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 168. SOUTH KOREA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 169. SOUTH KOREA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 170. REST OF ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 171. REST OF ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 172. REST OF ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 173. REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 174. REST OF ASIA-PACIFIC CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 175. REST OF ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 176. REST OF ASIA-PACIFIC IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 177. REST OF WORLD IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 178. REST OF WORLD IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 179. REST OF WORLD IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 180. REST OF WORLD MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 181. REST OF WORLD CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 182. REST OF WORLD IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 183. REST OF WORLD IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 184. REST OF WORLD IN VIRTO DIAGNOSTIC (IVD) MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 185. LATIN AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 186. LATIN AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 187. LATIN AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 188. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 189. LATIN AMERICA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 190. LATIN AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 191. LATIN AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 192. MIDDLE EAST IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 193. MIDDLE EAST IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 194. MIDDLE EAST IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 195. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 196. MIDDLE EAST CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 197. MIDDLE EAST IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 198. MIDDLE EAST IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 199. AFRICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
TABLE 200. AFRICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 201. AFRICA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 202. AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 203. AFRICA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
TABLE 204. AFRICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
TABLE 205. AFRICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
TABLE 206. BIOMERIEUX: COMPANY SNAPSHOT
TABLE 207. BIOMERIEUX: OPERATING SEGMENTS
TABLE 208. BIOMERIEUX: PRODUCT PORTFOLIO
TABLE 209. BIOMERIEUX: BUSINESS SEGMENT
TABLE 210. BIOMERIEUX: GEOGRAPHIC SEGMENT
TABLE 211. BIOMERIEUX: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 212. ROCHE HOLDING: COMPANY SNAPSHOT
TABLE 213. BIOMERIEUX: OPERATING SEGMENTS
TABLE 214. ROCHE HOLDINGS: PRODUCT PORTFOLIO
TABLE 215. ROCHE HOLDINGS: BUSINESS SEGMENT
TABLE 216. ROCHE HOLDINGS: GEOGRAPHIC SEGMENT
TABLE 217. ROCHE HOLDING: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 218. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 219. BIO-RAD LABORATORIES, INC: OPERATING SEGMENTS
TABLE 220. BIO-RAD LABORATORIES, INC: PRODUCT PORTFOLIO
TABLE 221. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 222. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 223. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 224. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 225. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 226. SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
TABLE 227. SIEMENS HEALTHINEERS AG: OPERATING SEGMENTS
TABLE 228. SIEMENS HEALTHINEERS AG: PRODUCT PORTFOLIO
TABLE 229. SIEMENS HEALTHINEERS AG: BUSINESS SEGMENT
TABLE 230. SIEMENS HEALTHINEERS AG: GEOGRAPHIC SEGMENT
TABLE 231. SIEMENS HEALTHINEERS AG: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 232. SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 233. SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 234. SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 235. SYSMEX CORPORATION: BUSINESS SEGMENT
TABLE 236. SYSMEX CORPORATION: GEOGRAPHIC SEGMENT
TABLE 237. SYSMEX CORPORATION: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 238. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 239. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 240. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 241. THERMO FISHER SCIENTIFIC: BUSINESS SEGMENT
TABLE 242. THERMO FISHER SCIENTIFIC: GEOGRAPHIC SEGMENT
TABLE 243. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 244. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 245. ABBOTT LABORATORIES: BUSINESS SEGMENTS
TABLE 246. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 247. ABBOTT LABORATORIES: BUSINESS SEGMENT
TABLE 248. ABBOTT LABORATORIES: GEOGRAPHIC SEGMENT
TABLE 249. ABBOTT LABORATORIES: KEY STRATEGIC MOVES & DEVELOPMENT
TABLE 250. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 251. QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 252. QIAGEN N.V.: GEOGRAPHIC SEGMENT
TABLE 253. QIAGEN N.V.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 254. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 255. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 256. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 257. DANAHER CORPORATION: BUSINESS SEGMENT
TABLE 258. DANAHER CORPORATION: KEY STRATEGIC MOVES & DEVELOPMENTS

LIST OF FIGURES
FIGURE 1. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
FIGURE 2. REAGENTS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 3. INSTRUMENTS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 4. SOFTWARE AND SERVICES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 5. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 6. GLOBAL IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 7. ELISA MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 8. RAPID TESTS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 9. ELISPOT MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 10. RADIOIMMUNOASSAY (RIA) MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 11. WESTERN BLOT MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 12. IMMUNODIAGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 13. HEMATOLOGY MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 15. PCR MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 16. INAAT MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 17. HYBRIDIZATION MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 18. DNA DIAGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 19. MICROARRAY MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 20. OTHERS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 21. MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 22. TISSUE DISGNOSTICS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 23. GLOBAL CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 24. BASIC METABOLIC PANEL MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 25. LIVER PANEL MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 26. RENAL PROFILE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 27. LIPID PROFILE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 28. THYROID FUNCTION PANEL MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 29. ELECTROLYTE PANEL MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 30. SPECIALITY CHEMICALS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 31. CLINICAL CHEMISTRY MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 32. OTHER IVD TECHNIQUES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 33. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 34. INFECTIOUS DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 35. CANCER MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 36. CARDIAC DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 37. IMMUNE SYSTEM DISORDERS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 38. NEPHROLOGICAL DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 39. GASTROINTESTINAL DISEASES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 40. OTHER INDICATIONS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 41. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
FIGURE 42. STAND ALONE LABORATORY MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 43. HOSPITALS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 44. ACADEMICS AND MEDICAL SCHOOLS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 45. POINT OF CARE TESTING MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 46. OTHERS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 47. GLOBAL IN VIRTO DIAGNOSTIC (IVD) MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 48. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
FIGURE 49. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 50. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 51. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 52. NORTH AMERICA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 53. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 54. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
FIGURE 55. NORTH AMERICA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 56. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
FIGURE 57. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 58. U.S. IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 59. U.S. MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 60. U.S. CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 61. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 62. U.S. IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
FIGURE 63. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
FIGURE 64. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 65. CANADA IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 66. CANADA MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 67. CANADA CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 68. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 69. CANADA IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
FIGURE 70. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
FIGURE 71. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 72. MEXICO IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 73. MEXICO MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 74. MEXICO CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 75. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 76. MEXICO IN VIRTO DIAGNOSTIC (IVD) MARKET, BY ENDUSER, 2021-2030, MILLION USD
FIGURE 77. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY PRODUCT TYPE, 2021-2030, MILLION USD
FIGURE 78. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 79. EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 80. EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 81. EUROPE CLINICAL CHEMISTRY MARKET, BY TECHNIQUE, 2021-2030, MILLION USD
FIGURE 82. EUROPE IN VIRTO DIAGNOSTIC (IVD) MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 83. EUROPE IN

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000040865

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。